Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01774513
Other study ID # 1212013
Secondary ID
Status Recruiting
Phase N/A
First received January 22, 2013
Last updated January 22, 2013
Start date January 2013

Study information

Verified date January 2013
Source Technische Universität München
Contact Stefan von Delius, MD
Email stefan_ruckert@yahoo.de
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The goal of this prospective study is to evaluate the feasibility of the Core Biopsy Needle with reverse bevel (Procore TM) in diagnosing autoimmune pancretitis


Recruitment information / eligibility

Status Recruiting
Enrollment 16
Est. completion date
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patient age 18 years and older

- patients with suspicion of autoimmune pancreatitis (based on the findings in EUS and MRI)

Exclusion Criteria:

- unable to obtain informed consent

- ASA class 4 and 5

- known pregnancy

- contraindication for endoscopy or for biopsy sampling

- patients with high suspicion on pancreatic cancer (based on the findings in radiology and EUS)

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
Procore-Needle


Locations

Country Name City State
Germany Klinikum rechts der Isar Munich Bavaria

Sponsors (1)

Lead Sponsor Collaborator
Technische Universität München

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary diagnostic yield Number of patients with adequate tissue sample (which allows definitive diagnosis) 6 months No
See also
  Status Clinical Trial Phase
Recruiting NCT03753815 - Diagnostic Yield of FNA Needle and FNB Needle for Autoimmune Pancreatitis N/A
Recruiting NCT02797665 - Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids N/A
Recruiting NCT04834505 - To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound
Recruiting NCT04397731 - Prospective Study on the Role of Eus-fnb in the Diagnosis of Autoimmune Pancreatitis
Not yet recruiting NCT06358001 - EchoTip AcuCore Post-Market Clinical Study
Completed NCT05476978 - Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
Recruiting NCT06369909 - Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
Completed NCT03241797 - Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis N/A
Completed NCT05171517 - Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
Withdrawn NCT01845467 - Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
Completed NCT05565066 - A Real-world Comparison of FNB and FNA in IHC-required Lesions.
Completed NCT02705638 - Treatment of IgG4-Related Disease With Revlimid and Rituximab Phase 1
Withdrawn NCT02766842 - Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) Phase 2
Completed NCT01584388 - Rituximab in IgG4-related Disease: A Phase 1-2 Trial Phase 1/Phase 2
Completed NCT00588367 - CT Pancreas Perfusion N/A